MENU
IMVT
AS OF
Jan 14, 04:59 PM (EDT)
Price
$27.34
Change
+$1.16 (+4.43%)
Capitalization
5.27B
35 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
IMVT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Immunovant (IMVT) Ownership - Who owns Immunovant?

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
320 West 37th Street
Phone
+1 917 580-3099
Employees
164
Web
https://www.immunovant.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
5.27B
P/E Ratio
N/A
Total Cash
521.87M
Projected Growth
N/A
Total Debt
98K
Revenue
N/A
Risk (Beta)
-0.66
Dividend Yield
N/A
Total Cash/Share
2.59
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

IMVT
Capitalization
5.28B
P/E Ratio
N/A
Risk (Beta)
-0.66
Dividend Yield
N/A
Total Cash
522M
Total Cash/Share
2.59
Total Debt
98K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
520M
P/B Ratio
10.15
Cash Flow
N/A
Earnings
-2.82
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
17K
Current Ratio
9.07
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-486.69M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-84.59
Shares Held By Institutions
2.36B
Shares Outstanding - Current
201M
Total Liabilities
63.3M
Total Volume MTD
N/A
Value
N/A
Gain YTD
2.990
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
IMVT
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IMVT showed earnings on November 10, 2025. You can read more about the earnings report here.
View AI-Driven Trading for IMVT
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company, which focuses on enabling normal lives for patients with autoimmune diseases.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
320 West 37th Street
Phone
+1 917 580-3099
Employees
164
Web
https://www.immunovant.com